The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
批准号:
10613905
负责人:
Archita P. Desai
金额:
$18.05万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-04-30
关键词:
Admission activityAlgorithmsBiometryBrainCalibrationCaregiver supportCaringCellular PhoneChronic DiseaseCirrhosisComplementDataData AnalysesData CorrelationsData SourcesDatabasesDementiaDisease ManagementEmergency department visitEquityFaceFutureGoalsGuidelinesHealthHealth Care ReformHealth TechnologyHealth systemHealthcareHealthcare SystemsHospitalizationIndividualInterventionLiverLiver diseasesMeasuresMedical RecordsMentorsMentorshipMethodologyMobile Health ApplicationModelingOutcome MeasurePatient EducationPatient Outcomes AssessmentsPatientsPerformancePopulationPredictive FactorProspective StudiesProspective cohortResearchResourcesRiskSymptomsTestingTimeTrainingTranslatingVulnerable Populationsbig data managementcohortcostdesignend stage liver diseaseevidence baseexperiencefeasibility testinghealth applicationhealth assessmenthealth care service utilizationhealth datahigh riskhospital readmissionimplementation scienceimprovedimproved outcomeinnovationinpatient servicemultidimensional datanovelpatient engagementpatient orientedpatient populationperformance testspersonalized medicinepopulation healthpredictive modelingprogramsprospectivereadmission ratesrisk predictionrisk prediction modelskillssocioeconomicssuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Management of cirrhosis is resource-intensive and disproportionately contributes a growing burden on
healthcare. Inpatient care is a sizeable portion of this burden where nearly 30% of admissions result in a
readmission within 30 days. Unfortunately, health system-based interventions successful in reducing
readmission rates face important barriers to dissemination. In order for successful health delivery redesign to
occur, it is important to target the right patient and deliver a tailored intervention. Precisely segmenting patient
populations to identify high utilizers is an important first step. Current readmission prediction models based on
traditional medical records data have weak performance in cirrhosis. Instead, our novel preliminary data correlate
patient reported outcome measures (PROMs) to future healthcare utilization (HCU). Further, the PI’s mentor has
shown that when healthcare systems combine real-time PRO tracking with evidence-based management
algorithms and patient-facing health tools, HCU burden can be reduced. Based on these data, this proposal will
first test the overarching hypothesis that a combination of EHR-based and non-EHR, patient-centered measures
will better identify high utilizers in cirrhosis. Taken a step further, this proposal will also test the hypothesis that
successful, scalable models of care can be translated to high-risk cirrhotics through adaptation of a health
technology tool. We will test these hypotheses via three aims and a robust training plan. Specific Aim #1 will
assess HCU prediction by existing risk models and then utilize a state-wide data source to further refine risk
prediction with liver disease-specific and population health data. Specific Aim #2 will further calibrate prediction
of future HCU using PROMs in a prospective cohort of hospitalized cirrhotics. With the ability to identify a
vulnerable group of cirrhotics from SA#s 1-2, Specific Aim #3 will build on the co-mentor’s (Dr. Boustani)
success in improving HCU in dementia populations by adapting Brain Care Notes, a mobile phone health
application designed to support real-time symptom tracking, care-giver support and engagement to reduce HCU
in those with cirrhosis. Further, while completing these aims, the PI will accomplish 3 interdisciplinary training
goals: 1) develop advanced biostatistical and big data management and analysis skills; 2) acquire experience
in methodologies needed for the study of PROMs; 3) gain expertise in healthcare implementation science
research all under the guidance of a robust mentorship team led by national experts in the proposed fields.
Successful completion of these aims will support the design of a future R01-level intervention that provides
innovative, scalable solutions for the chronic disease management in cirrhosis.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1001/jamanetworkopen.2023.24539
发表时间:
2023-07-03
期刊:
JAMA network open
影响因子:
13.8
作者:
[]
通讯作者:
DOI:
10.1016/j.cgh.2021.07.032
发表时间:
2022-06
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
[Orman ES, Ghabril MS, Desai AP, Nephew L, Patidar KR, Gao S, Xu C, Chalasani N]
通讯作者:
Chalasani N
DOI:
10.1016/j.jhepr.2023.100955
发表时间:
2024-01
期刊:
JHEP REPORTS
影响因子:
8.3
作者:
[Desai, Archita P., Parvataneni, Swetha, Knapp, Shannon M., Nephew, Lauren D., Chalasani, Naga, Ghabril, Marwan S., Orman, Eric S.]
通讯作者:
Orman, Eric S.
Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis.
衡量肝硬化患者的药物使用情况、障碍和知识。
DOI:
10.1016/j.cgh.2022.08.025
发表时间:
2023
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
作者:
[Desai,ArchitaP, Duzdar,Shahd, Stump,Timothy, Orman,EricS, Nephew,Lauren, Patidar,KavishR, Ghabril,MarwanS, Block,Geoffrey, Fallon,Michael, Chalasani,Naga, Monahan,PatrickO]
通讯作者:
Monahan,PatrickO
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time.
PRIMER 研究:一步一步地促使肝病患者养成更健康的习惯。
DOI:
10.1097/lvt.0000000000000235
发表时间:
2024
期刊:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
影响因子:
--
作者:
[Orman,EricS, Desai,ArchitaP]
通讯作者:
Desai,ArchitaP
共 9 条
The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
-
批准号:10217128
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2020
-
负责人:Archita P. Desai
-
依托单位:
The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
-
批准号:10398143
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2020
-
负责人:Archita P. Desai
-
依托单位:
The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis
-
批准号:10055401
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2020
-
负责人:Archita P. Desai
-
依托单位:
海外基金